Literature DB >> 19850770

Kidney transplantation in the context of renal replacement therapy.

Todd E Pesavento1.   

Abstract

Kidney transplantation has dramatically evolved from a life-saving yet unproven therapy for patients with renal failure to a mature field that is the preferred treatment for those suffering from ESRD. Patients who receive a transplant experience a 68% lower risk of death compared with those waiting on dialysis for a transplant. This benefit is afforded to all patient subgroups including the elderly (> or =70 yr), and diabetics, who can gain 11 yr of extra life with transplantation. Prolonged transplant wait times result in a higher risk of death but this can be ameliorated with preemptive transplantation. Future challenges will focus on appropriate organ allocation and addressing long-term renal function and comorbid conditions so patients can enjoy the full benefits of transplantation.

Entities:  

Mesh:

Year:  2009        PMID: 19850770     DOI: 10.2215/CJN.05500809

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   8.237


  9 in total

1.  GATA1 regulates the microRNA‑328‑3p/PIM1 axis via circular RNA ITGB1 to promote renal ischemia/reperfusion injury in HK‑2 cells.

Authors:  Yang Gao; Weijia Xu; Chen Guo; Tao Huang
Journal:  Int J Mol Med       Date:  2022-06-08       Impact factor: 5.314

2.  The Potential Diagnostic Value of Immune-Related Genes in Interstitial Fibrosis and Tubular Atrophy after Kidney Transplantation.

Authors:  Bin Yang; Dike Shi; Yahong Chen; Yi Zhu
Journal:  J Immunol Res       Date:  2022-06-17       Impact factor: 4.493

3.  Characteristics and Outcomes of Kidney Transplant Recipients with a Functioning Graft for More than 25 Years.

Authors:  Sandesh Parajuli; Didier A Mandelbrot; Fahad Aziz; Neetika Garg; Brenda Muth; Maha Mohamed; Michael J Armbrust; Brad C Astor; Arjang Djamali
Journal:  Kidney Dis (Basel)       Date:  2018-07-27

Review 4.  Uraemic solutes as therapeutic targets in CKD-associated cardiovascular disease.

Authors:  Jonathan D Ravid; Mohamed Hassan Kamel; Vipul C Chitalia
Journal:  Nat Rev Nephrol       Date:  2021-03-23       Impact factor: 28.314

Review 5.  Transplanting Marginal Organs in the Era of Modern Machine Perfusion and Advanced Organ Monitoring.

Authors:  Thomas Resch; Benno Cardini; Rupert Oberhuber; Annemarie Weissenbacher; Julia Dumfarth; Christoph Krapf; Claudia Boesmueller; Dietmar Oefner; Michael Grimm; Sefan Schneeberger
Journal:  Front Immunol       Date:  2020-05-12       Impact factor: 7.561

6.  Acute Esophageal Necrosis Early after Renal Transplantation.

Authors:  Ahmad Makeen; Faisal Al-Husayni; Turki Banamah
Journal:  Case Rep Nephrol       Date:  2021-10-15

Review 7.  The Impact of Human Microbiotas in Hematopoietic Stem Cell and Organ Transplantation.

Authors:  Tirthankar Sen; Rajkumar P Thummer
Journal:  Front Immunol       Date:  2022-07-07       Impact factor: 8.786

8.  Urinary sulfate excretion and risk of late graft failure in renal transplant recipients - a prospective cohort study.

Authors:  M Yusof Said; Adrian Post; Isidor Minović; Marco van Londen; Harry van Goor; Douwe Postmus; M Rebecca Heiner-Fokkema; Else van den Berg; Andreas Pasch; Gerjan Navis; Stephan J L Bakker
Journal:  Transpl Int       Date:  2020-03-23       Impact factor: 3.782

9.  Histopathological characteristics and causes of kidney graft failure in the current era of immunosuppression.

Authors:  Sandesh Parajuli; Fahad Aziz; Neetika Garg; Sarah E Panzer; Emily Joachim; Brenda Muth; Maha Mohamed; Justin Blazel; Weixiong Zhong; Brad C Astor; Didier A Mandelbrot; Arjang Djamali
Journal:  World J Transplant       Date:  2019-10-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.